Tsingke, Biotech

Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements

17.03.2026 - 23:17:29 | prnewswire.co.uk

Beijing Tsingke Biotech Co., Ltd. China

is a leading innovator in synthetic biology, with a mission to build "the world's great gene factory." Combining proprietary reagents, consumables, and synthesis equipment with AI-driven molecular manufacturing technologies, Tsingke Biotech provides efficient and high-quality gene synthesis services. Its work supports industries ranging from biopharma to agriculture, food, and environmental sciences.

About iGeneTech

iGeneTech specializes in gene capture technologies and holds intellectual property in NGS probe hybridization, multiplex PCR, and high-throughput DNA synthesis. The company's high-quality oligo pool synthesis capabilities enable the creation of precise and uniform sgRNA libraries for gene-editing applications, including genome-wide and target-gene sgRNA libraries, and off-target detection.

Contact: market@tsingke.com.cn 

Photo - https://mma.prnewswire.com/media/2928790/The_partnership_formalized_a_signing_ceremony_held_Tsingke_Biotech_s_Beijing.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/tsingke-biotech-and-igenetech-forge-strategic-partnership-to-lead-synthetic-biology-advancements-302707970.html

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

 <b>Hol dir jetzt den Wissensvorsprung der Aktien-Profis.</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Aktien-Empfehlungen - Dreimal die Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
CH0038389992 | TSINGKE | boerse | 68752565 |